Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00879944 · ClinicalTrials.gov registry record
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
A clinical trial of Atopic Dermatitis and Psoriasis, sponsored by Northwestern University.
- Completed
- Registry status
- 409
- Enrollment target
- 14
- Study locations
NCT00879944 is a study of Atopic Dermatitis and Psoriasis that has completed, run by Northwestern University. The registered enrollment target is 409 participants, below the 607-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (33% lower). The trial reports 14 study locations across 8 states.
The verdict
NCT00879944, a study of Atopic Dermatitis and Psoriasis, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 409 participants
- Enrollment target
- 14
- Study locations
Study Summary
The object of this research study is to examine these associations in children as very little is known about psoriasis and cardiovascular risk factors in the pediatric population.
Conditions Studied
Interventions
- OTHER Blood pressure
- OTHER Height
- OTHER Weight
- OTHER BMI
- OTHER Waist Circumference
Study Locations (14)
Other
- Pontificia Universidad Catolica de Chile - Santiago
- University of Hong Kong - Tuenmen
- Universita Verona - Verona
- UMC St. Radboud - Nijmegen
California
- University of California, San Diego - San Diego
- University of California, San Francisco - San Francisco
- Stanford University School of Medicine - Stanford
Texas
- Texas Dermatology Associates - Dallas
- Texas Children's Hospital - Houston
Illinois
- Ann & Robert H Lurie Children's Hospital of Chicago - Chicago
Massachusetts
- UMass Memorial Dermatology Center - Worcester
Missouri
- Central Dermatology - St Louis
Ohio
- University Hospitals, Case Medical Centers - Cleveland
Newfoundland and Labrador
- Nexus Clinical Resarch - St. John's
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 409 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00879944
The ClinicalTrials.gov registry entry for NCT00879944 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 409 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 607-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (33% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Atopic Dermatitis appearing as the primary indexed condition, and to 5 interventions - of which Blood pressure is the first listed.
NCT00879944 reports 14 study locations spanning 8 distinct geographic areas - top geographies include Other, California, Texas.
Frequently Asked Questions
What is clinical trial NCT00879944 about?
NCT00879944 is a clinical study titled "Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index". The object of this research study is to examine these associations in children as very little is known about psoriasis and cardiovascular risk factors in the pediatric population.
What is the current status of trial NCT00879944?
This trial is currently completed. The enrollment target is 409 participants. The study started on 2009-05. Estimated completion is 2012-07.
What conditions does trial NCT00879944 study?
This clinical trial studies the following conditions: Atopic Dermatitis, Psoriasis.
What interventions are being tested in trial NCT00879944?
The interventions under investigation include: Blood pressure (OTHER), Height (OTHER), Weight (OTHER), BMI (OTHER), Waist Circumference (OTHER).
Who is sponsoring clinical trial NCT00879944?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00879944 being conducted?
This trial has 14 study locations across California, Illinois, Massachusetts, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atopic Dermatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry for Systemic Eczema Treatments
RECRUITING
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
RECRUITING
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RECRUITING · Phase 2
-
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
RECRUITING · Phase 1
-
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.